{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T04:56:02Z","timestamp":1770785762382,"version":"3.50.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001429","name":"Indo-US Science and Technology Forum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005808","name":"Indian Institute of Technology Bombay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/S3\/CE\/54\/2008"],"award-info":[{"award-number":["SR\/S3\/CE\/54\/2008"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ijpharm.2012.03.030","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T20:05:40Z","timestamp":1332533140000},"page":"228-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices"],"prefix":"10.1016","volume":"430","author":[{"given":"Amol Ashok","family":"Pawar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Ren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra","family":"Venkataraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.03.030_bib0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3844\/ajptsp.2008.219.224","article-title":"Tamoxifen drug loading solid lipid nanoparticles prepared by hot high pressure homogenization techniques","volume":"3","author":"Alhaj","year":"2008","journal-title":"Am. J. Pharm. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0010","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.addr.2006.09.007","article-title":"Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems","volume":"58","author":"Arifin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2007.04.002","article-title":"Pharmacokinetics of gefitinib in humans: the influence of gastrointestinal factors","volume":"341","author":"Bergman","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0011-9164(84)85049-3","article-title":"Effect of crystallinity and swelling on the permeability and selectivity of polymer membranes","volume":"51","author":"Bitter","year":"1984","journal-title":"Desalination"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0025","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.2042-7158.2010.01024.x","article-title":"Lipid nanoparticles for the delivery of poorly water-soluble drugs","volume":"62","author":"Bunjes","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-5173(95)04286-5","article-title":"Crystallization tendency and polymorphic transitions in triglyceride nanoparticles","volume":"129","author":"Bunjes","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2009.06.001","article-title":"Lipid \u2013 an emerging platform for oral delivery of drugs with poor bioavailability","volume":"73","author":"Chakraborty","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1634\/theoncologist.8-4-303","article-title":"FDA drug approval summary: Gefitinib (ZD1839) (Iressa(R)) tablets","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0045","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1351\/pac198557111681","article-title":"Molecular diffusion in polymeric systems","volume":"57","author":"Duda","year":"1985","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0050","series-title":"Transmission Electron Microscopy and Diffractometry of Materials","author":"Fultz","year":"2008"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0055","series-title":"Aerosol Technology: Properties, behavior, and Measurement of Airborne Particles","author":"Hinds","year":"1999"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.colsurfb.2005.08.005","article-title":"Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system","volume":"45","author":"Hu","year":"2005","journal-title":"Colloids Surf. B: Biointerf."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0065","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/02786829308959653","article-title":"Modeling of solid particle formation during solution aerosol thermolysis","volume":"19","author":"Jayanthi","year":"1993","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0168-3659(03)00367-5","article-title":"Effects of crystalline microstructure on drug release behavior of poly(\u025b-caprolactone) microspheres","volume":"92","author":"Jeong","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.nano.2010.06.003","article-title":"Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax","volume":"6","author":"Kheradmandnia","year":"2010","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2009.09.008","article-title":"Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release","volume":"383","author":"Kim","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0085","series-title":"The Theory and Practice of Industrial Pharmacy","author":"Lachman","year":"1986"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles \u2013 production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art","volume":"50","author":"Muller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ejpb.2007.07.006","article-title":"Cyclosporine-loaded solid lipid nanoparticles (SLN\u00ae): drug-lipid physicochemical interactions and characterization of drug incorporation","volume":"68","author":"Muller","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1020159331420","article-title":"Enzymatic degradation of Dynasan 114 SLN \u2013 effect of surfactants and particle size","volume":"4","author":"Olbrich","year":"2002","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(02)00035-2","article-title":"Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN) \u2013 effect of surfactants, storage time and crystallinity","volume":"237","author":"Olbrich","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0115","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2009","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.addr.2009.11.007","article-title":"Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer","volume":"62","author":"Patra","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/02786826.2011.565089","article-title":"Droplet-phase synthesis of nanoparticle aerosol lipid matrices with controlled properties","volume":"45","author":"Pawar","year":"2011","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0130","series-title":"Perry's Chemical Engineers\u2019 Handbook","author":"Perry","year":"1999"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-8502(02)00153-2","article-title":"Lattice-Boltzmann approach for description of the structure of deposited particulate matter in fibrous filters","volume":"34","author":"Przekop","year":"2003","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0140","first-page":"785","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nat. Rev."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0145","article-title":"Aerosol synthesis of lipid nanoparticles: relating crystallinity to simulated evaporation rates","author":"Shetty","year":"2011","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0150","first-page":"508","article-title":"Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin","volume":"37","author":"Subedi","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0155","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/S0009-2509(01)00041-0","article-title":"Clogging of fibrous filters by solid aerosol particles: experimental and modelling study","volume":"56","author":"Thomas","year":"2001","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0160","series-title":"Mass-transfer Operations","author":"Treybal","year":"1981"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0165","first-page":"289","article-title":"Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives","volume":"2","author":"Uner","year":"2007","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0170","series-title":"A Method and a System for Producing Thermolabile Nanoparticles with Controlled Properties and Nanoparticles Matrices Made Thereby","author":"Venkataraman","year":"2011"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0175","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","article-title":"Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles","volume":"95","author":"Venkateswarlu","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0180","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/smll.201000253","article-title":"Fabrication of metallized nanopores in silicon nitride membranes for single-molecule sensing","volume":"6","author":"Wei","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(97)00046-1","article-title":"Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential","volume":"48","author":"Westesen","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0190","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.addr.2007.04.008","article-title":"Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles","volume":"59","author":"Wong","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.03.030_bib0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 drug release and release mechanism","volume":"45","author":"zur Muhlen","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312002712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312002712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:31:14Z","timestamp":1759915874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312002712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0378517312002712"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.03.030","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}